Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Scorpion Biological Services
Sort By
Newest First
1 / 1
Acquirement
Lilly to Acquire Scorpion Therapeutics' Mutant-Selective PI3Kα Inhibitor Program
Eli Lilly and Company
PR-01-25-NI-14
Jan 14, 2025
Biomanufacturing
Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion
Scorpius BioManufacturing
PR-M12-22-02
Dec 21, 2022
New Facility
Scorpion Biological Services Celebrates Grand Opening of its San Antonio Facility
Scorpius BioManufacturing
PR-M10-22-08
Oct 27, 2022
Biodefense
Supporting Biodefense Countermeasures with Strong Capabilities and Expertise
Brian O’Mara
Scorpius BioManufacturing
PAO-09-022-CL-03
Sep 19, 2022
CRDMO
Scorpion Biological Services Appoints Stephan Kutzer, Ph.D. as Interim Chief Executive Officer (CEO)
Scorpius BioManufacturing
PR-M06-22-03
Jun 14, 2022
Bioanalytics
The Bioanalytical Development Journey
Nick Raja, Ph.D.
Scorpius BioManufacturing
PAO-05-022-CL-03
May 09, 2022
New Biodefense Facility
Scorpion Biological Services Announces New Kansas Commercial Biomanufacturing Facility
Scorpius BioManufacturing
PR-M04-22-12
Apr 26, 2022
New Biodefense Facility
Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing Facility
Heat Biologics
PR-M04-22-10
Apr 18, 2022
Bioanalytics
Integrating and Automating Biomanufacturing and Bioanalytics
Scorpius BioManufacturing
PAO-02-22-R250-12
Feb 11, 2022
Single-Use Technologies
Evaluating Single-Use Technologies for Biomanufacturing
Chris Barnett
Scorpius BioManufacturing
PAO-11-21-CL-08
Nov 22, 2021
1 / 1
